Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations (AML18)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02272478 |
|
Recruitment Status : Unknown
Verified August 2019 by Prof Nigel Russell, Cardiff University.
Recruitment status was: Recruiting
First Posted : October 23, 2014
Last Update Posted : January 23, 2020
|
Sponsor:
Cardiff University
Collaborator:
Cancer Research UK
Information provided by (Responsible Party):
Prof Nigel Russell, Cardiff University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | February 2021 |
| Estimated Study Completion Date : | February 2022 |